Department of Pediatrics Archive — Page 30 of 58

Portrait of a smiling woman with long gray-blonde hair and glasses, wearing a patterned jacket over a black top.
May 27, 2021

Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track

A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.

May 26, 2021

Predicting blood clots before they happen in pediatric patients

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
May 26, 2021

American Pediatric Association honors two Children’s Hospital pediatricians

Two physicians in Vanderbilt’s Department of Pediatrics — James Antoon, MD, PhD, and Shani Jones, MD — have been honored for their work by the American Pediatric Association.

May 20, 2021

New clue to lung scarring

Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases.

Portrait of a smiling woman with long dark hair wearing a dark top against a neutral background.
May 17, 2021

Goode, Hine receive 2021 Geoffrey David Chazen Faculty Award for Innovation in Medical Education

Rachel Goode, MD, and Jeffrey Hine, MD, are the recipients of the 2021 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.

Medical-style illustration of red blood cells flowing through a blood vessel, with a cutaway section showing cells inside the vessel.
May 12, 2021

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.